Trials / Unknown
UnknownNCT05457114
Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver Transplantation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,970 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The investigators attempted to evaluate whether the use of PAC is associated with better clinical outcomes after liver transplantation compared with the case without PAC.
Detailed description
Pulmonary artery catheter (PAC) has been used for advanced hemodynamic monitoring during liver transplantation. However, recent advances in less invasive monitoring could provide continuous cardiac output monitoring by arterial waveform analysis. Using this technology, stroke volume variation (SVV) is monitored as a preload index. Calculated systemic vascular resistance (SVR) can be monitored if central venous pressure (CVP) is provided. Therefore, this less invasive form of hemodynamic monitoring may replace the PAC. The investigators attempted to evaluate whether the use of PAC is associated with better clinical outcomes after liver transplantation compared with the case without PAC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pulmonary artery catheter (Edward Lifesciences, Irvine, California, USA) | PAC was inserted and connected to a continuous cardiac output monitor (Vigilance I from 2006 to 2012; Vigilance II from 2012 to 2022, Edward Lifesciences, Irvine, USA) |
| DEVICE | FloTrac Vigileo system (EV1000 clinical platform, Edward Lifesciences, Irvine, California, USA) | Without PAC, monitoring with FloTrac Vigileo system (EV1000 clinical platform, Edward Lifesciences, Irvine, California, USA) was performed for continuous cardiac output monitoring. |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2022-07-13
- Last updated
- 2022-07-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05457114. Inclusion in this directory is not an endorsement.